Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Quijada-Álamo, Miguel
111  Ergebnisse:
Personensuche X
?
1

The Five "Ws" of Frailty Assessment and Chronic Lymphocytic..:

González-Gascón-y-Marín, Isabel ; Ballesteros-Andrés, Mónica ; Martínez-Flores, Sara...
Cancers.  15 (2023)  17 - p. 4391 , 2023
Link: https://doi.org/10.3390/..
 
?
2

High expression level of ROR1 and ROR1-signaling associates..:

Ghia, Emanuela M. ; Rassenti, Laura Z. ; Choi, Michael Y....
Leukemia.  36 (2022)  6 - p. 1609-1618 , 2022
Link: https://doi.org/10.1038/..
 
?
3

From Biomarkers to Models in the Changing Landscape of Chro..:

González-Gascón-y-Marín, Isabel ; Muñoz-Novas, Carolina ; Rodríguez-Vicente, Ana-Eugenia...
Cancers.  13 (2021)  8 - p. 1782 , 2021
Link: https://doi.org/10.3390/..
 
?
4

Biological significance of monoallelic and biallelic BIRC3 ..:

Quijada-Álamo, Miguel ; Hernández-Sánchez, María ; Rodríguez-Vicente, Ana-Eugenia...
Blood Cancer Journal.  11 (2021)  7 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
5

The Evolving Landscape of Chronic Lymphocytic Leukemia on D..:

Pérez-Carretero, Claudia ; González-Gascón-y-Marín, Isabel ; Rodríguez-Vicente, Ana E....
Diagnostics.  11 (2021)  5 - p. 853 , 2021
Link: https://doi.org/10.3390/..
 
?
6

CRISPR/Cas9-generated models uncover therapeutic vulnerabil..:

Quijada-Álamo, Miguel ; Hernández-Sánchez, María ; Alonso-Pérez, Verónica...
Leukemia.  34 (2020)  6 - p. 1599-1612 , 2020
Link: https://doi.org/10.1038/..
 
?
7

Prognosis Assessment of Early-Stage Chronic Lymphocytic Leu..:

González-Gascón-y-Marín, Isabel ; Muñoz-Novas, Carolina ; Figueroa, Iñigo...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  8 - p. 548-555.e4 , 2020
Link: https://doi.org/10.1016/..
 
?
8

DNA damage response-related alterations define the genetic ..:

Hernández-Sánchez, María ; Rodríguez-Vicente, Ana Eugenia ; González-Gascón y Marín, Isabel...
Experimental Hematology.  72 (2019)  - p. 9-13 , 2019
Link: https://doi.org/10.1016/..
 
?
9

CLL cells cumulate genetic aberrations prior to the first t..:

Hernández-Sánchez, María ; Kotaskova, Jana ; Rodríguez, Ana E...
Leukemia.  33 (2018)  2 - p. 518-558 , 2018
Link: https://doi.org/10.1038/..
 
?
10

Mutations in TP53 and JAK2 are independent prognostic bioma..:

Forero-Castro, Maribel ; Robledo, Cristina ; Benito, Rocío...
British Journal of Cancer.  117 (2017)  2 - p. 256-265 , 2017
Link: https://doi.org/10.1038/..
 
?
11

Next-generation sequencing and FISH studies reveal the appe..:

Quijada-Álamo, Miguel ; Hernández-Sánchez, María ; Robledo, Cristina...
Journal of Hematology & Oncology.  10 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
12

The CRISPR/Cas9 system efficiently reverts the tumorigenic ..:

García-Tuñón, Ignacio ; Hernández-Sánchez, María ; Ordoñez, José Luis...
Oncotarget.  8 (2017)  16 - p. 26027-26040 , 2017
Link: https://doi.org/10.18632..
 
?
13

High expression level of ROR1 and ROR1-signaling associates..:

Ghia, Emanuela M ; Rassenti, Laura Z ; Choi, Michael Y...
Publisher's version.  , 2022
Link: http://hdl.handle.net/10..
 
?
14

High expression level of ROR1 and ROR1-signaling associates..:

Ghia, Emanuela M ; Rassenti, Laura Z ; Choi, Michael Y...
qt5ht6f45c.  , 2022
Link: https://escholarship.org..
 
?
15

High expression level of ROR1 and ROR1-signaling associates..:

Ghia, Emanuela M ; Rassenti, Laura Z ; Choi, Michael Y...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162914/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15